Medtronic Boasts Positive Results for Self-Expanding Stent

After a three-year trial, Medtronic is touting positive results for the EverFlex self-expanding stent for treating peripheral artery disease it acquired when it bought Covidien for $50 billion, according to MassDevice.com.  “The global medical device giant said...